{
  "url": "https://finance.yahoo.com/news/strong-financial-prospects-force-driving-052858250.html",
  "authorsByline": "Simply Wall St",
  "articleId": "80f3ccebd72a40cd911fa7590c09ae44",
  "source": {
    "domain": "finance.yahoo.com",
    "location": {
      "country": "us",
      "state": "CA",
      "county": "Santa Clara County",
      "city": "Sunnyvale",
      "coordinates": {
        "lat": 37.3688301,
        "lon": -122.036349
      }
    }
  },
  "imageUrl": "https://media.zenfs.com/en/simply_wall_st__316/8e5b7feff946a5236949391477b36a92",
  "country": "us",
  "language": "en",
  "pubDate": "2025-08-12T05:28:58+00:00",
  "addDate": "2025-08-12T05:42:23.635782+00:00",
  "refreshDate": "2025-08-12T05:42:23.635786+00:00",
  "score": 1.0,
  "title": "Are Strong Financial Prospects The Force That Is Driving The Momentum In Volex plc's LON:VLX) Stock?",
  "description": "AIM:VLX 1 Year Share Price vs Fair Value Explore Volex's Fair Values from the Community and select yours Volex...",
  "content": "Explore Volex's Fair Values from the Community and select yours\n\n\n\nVolex (LON:VLX) has had a great run on the share market with its stock up by a significant 34% over the last three months. Given the company's impressive performance, we decided to study its financial indicators more closely as a company's financial health over the long-term usually dictates market outcomes. Particularly, we will be paying attention to Volex's ROE today.\n\nReturn on equity or ROE is a key measure used to assess how efficiently a company's management is utilizing the company's capital. Put another way, it reveals the company's success at turning shareholder investments into profits.\n\nAI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.\n\nReturn on equity can be calculated by using the formula:\n\nSo, based on the above formula, the ROE for Volex is:\n\n13% = US$49m \u00f7 US$370m (Based on the trailing twelve months to March 2025).\n\nThe 'return' is the amount earned after tax over the last twelve months. One way to conceptualize this is that for each \u00a31 of shareholders' capital it has, the company made \u00a30.13 in profit.\n\nWhy Is ROE Important For Earnings Growth?\n\nSo far, we've learned that ROE is a measure of a company's profitability. Based on how much of its profits the company chooses to reinvest or \"retain\", we are then able to evaluate a company's future ability to generate profits. Assuming all else is equal, companies that have both a higher return on equity and higher profit retention are usually the ones that have a higher growth rate when compared to companies that don't have the same features.\n\nA Side By Side comparison of Volex's Earnings Growth And 13% ROE\n\nAt first glance, Volex seems to have a decent ROE. And on comparing with the industry, we found that the the average industry ROE is similar at 13%. This probably goes some way in explaining Volex's moderate 12% growth over the past five years amongst other factors.\n\nAs a next step, we compared Volex's net income growth with the industry and found that the company has a similar growth figure when compared with the industry average growth rate of 12% in the same period.\n\nEarnings growth is a huge factor in stock valuation. The investor should try to establish if the expected growth or decline in earnings, whichever the case may be, is priced in. This then helps them determine if the stock is placed for a bright or bleak future. Is Volex fairly valued compared to other companies? These 3 valuation measures might help you decide.",
  "medium": "Article",
  "links": [
    "https://simplywall.st/company/id/EC2EBDE3-CDAF-4D15-BF4E-0EAF04B38F06?blueprint=3982641&utm_medium=finance_user&utm_campaign=cta&utm_source=yahoo",
    "https://simplywall.st/company/id/EC2EBDE3-CDAF-4D15-BF4E-0EAF04B38F06/past?blueprint=3982641&amp;utm_medium=finance_user&amp;utm_campaign=infographic&amp;utm_source=yahoo",
    "https://simplywall.st/discover/investing-ideas/434426/us-transformative-artificial-intelligence-ai-healthcare-stocks/global?blueprint=3982641&utm_medium=finance_user&utm_campaign=investing-ideas&utm_source=yahoo&utm_content=ai-healthcare",
    "https://simplywall.st/company/id/EC2EBDE3-CDAF-4D15-BF4E-0EAF04B38F06/valuation?blueprint=3982641&utm_medium=finance_user&utm_campaign=conclusion&utm_source=yahoo",
    "https://au.finance.yahoo.com/quote/VLX.L",
    "https://simplywall.st/company/id/EC2EBDE3-CDAF-4D15-BF4E-0EAF04B38F06?blueprint=3982641&utm_medium=finance_user&utm_campaign=narratives-news-header&utm_source=yahoo&utm_content=narrative-header-company-report"
  ],
  "labels": [
    {
      "name": "Non-news"
    }
  ],
  "claim": "",
  "verdict": "",
  "keywords": [
    {
      "name": "other companies",
      "weight": 0.104963444
    },
    {
      "name": "companies",
      "weight": 0.103700526
    },
    {
      "name": "Volex",
      "weight": 0.0965898
    },
    {
      "name": "Earnings Growth",
      "weight": 0.093820594
    },
    {
      "name": "Earnings growth",
      "weight": 0.093820594
    },
    {
      "name": "stock valuation",
      "weight": 0.07323024
    },
    {
      "name": "higher profit retention",
      "weight": 0.07280283
    },
    {
      "name": "ROE",
      "weight": 0.07109302
    },
    {
      "name": "Volexs Earnings Growth",
      "weight": 0.07087959
    },
    {
      "name": "Volexs net income growth",
      "weight": 0.06960459
    }
  ],
  "topics": [],
  "categories": [
    {
      "name": "Finance"
    }
  ],
  "taxonomies": [
    {
      "name": "/News/Business News/Financial Markets News",
      "score": 0.9921875
    },
    {
      "name": "/Finance/Investing/Stocks & Bonds",
      "score": 0.984375
    },
    {
      "name": "/News/Business News/Company News",
      "score": 0.984375
    },
    {
      "name": "/Finance/Investing/Other",
      "score": 0.402587890625
    },
    {
      "name": "/Business & Industrial/Pharmaceuticals & Biotech",
      "score": 0.339599609375
    }
  ],
  "sentiment": {
    "positive": 0.5616999,
    "negative": 0.060547534,
    "neutral": 0.37775254
  },
  "summary": "Volex plc's stock has risen by 34% over the last three months, with the company's financial performance closely studied. The company's return on equity (ROE) is a key measure used to assess how efficiently a company's management is utilising its capital. ROE is a measure of a company\u2019s profitability, based on how much of its profits are reinvested or retained. Companies with both a higher return on Equity and higher profit retention are usually the ones with a higher growth rate compared to companies without these features. Volex's ROE, compared with the industry's average ROE of 13%. Earnings growth is a crucial factor in stock valuation and can be used to determine if the company is valued well.",
  "shortSummary": "Volex plc's strong financial performance and strong profitability are driving its stock market rise, with strong returns and long-term earnings influencing its valuation.",
  "translation": "",
  "translatedTitle": "",
  "translatedDescription": "",
  "translatedSummary": "",
  "reprint": false,
  "reprintGroupId": "7b6049a041b94757b2e78d6e2b614ad7",
  "places": [],
  "scraped_sources": [
    {
      "url": "https://simplywall.st/company/id/EC2EBDE3-CDAF-4D15-BF4E-0EAF04B38F06/past?blueprint=3982641&amp;utm_medium=finance_user&amp;utm_campaign=infographic&amp;utm_source=yahoo",
      "text": "Volex Past Earnings Performance\nPast criteria checks 5/6\nVolex has been growing earnings at an average annual rate of 12.2%, while the Electrical industry saw earnings growing at 12.2% annually. Revenues have been growing at an average rate of 21.4% per year. Volex's return on equity is 13.2%, and it has net margins of 4.4%.\nKey information\n12.17%\nEarnings growth rate\n7.39%\nEPS growth rate\n| Electrical Industry Growth | 8.55% |\n| Revenue growth rate | 21.37% |\n| Return on equity | 13.24% |\n| Net Margin | 4.41% |\n| Last Earnings Update | 30 Mar 2025 |\nRecent past performance updates\nRecent updates\nVolex (LON:VLX) Has Announced That It Will Be Increasing Its Dividend To $0.03\nJul 17Volex plc's (LON:VLX) 26% Price Boost Is Out Of Tune With Earnings\nJul 06Volex (LON:VLX) Is Increasing Its Dividend To $0.03\nJul 02Volex (LON:VLX) Hasn't Managed To Accelerate Its Returns\nJun 27Volex plc's (LON:VLX) 27% Dip In Price Shows Sentiment Is Matching Earnings\nApr 05EV Partnerships, Including Tesla, Will Drive Future Opportunities\nStrategic expansions and partnerships in emerging and high-growth sectors like EVs position Volex for robust future revenue growth.Here's What To Make Of Volex's (LON:VLX) Decelerating Rates Of Return\nJan 15Earnings Tell The Story For Volex plc (LON:VLX)\nDec 13Volex (LON:VLX) Will Pay A Dividend Of $0.015\nNov 18Volex plc's (LON:VLX) Intrinsic Value Is Potentially 24% Below Its Share Price\nNov 16We Think That There Are Some Issues For Volex (LON:VLX) Beyond Its Promising Earnings\nJul 05Volex's (LON:VLX) Upcoming Dividend Will Be Larger Than Last Year's\nJun 29Volex plc (LON:VLX) Stocks Shoot Up 25% But Its P/E Still Looks Reasonable\nMay 10Is Now The Time To Put Volex (LON:VLX) On Your Watchlist?\nApr 19We Think Volex (LON:VLX) Can Stay On Top Of Its Debt\nFeb 22At UK\u00a32.88, Is It Time To Put Volex plc (LON:VLX) On Your Watch List?\nOct 10Is Volex (LON:VLX) A Risky Investment?\nAug 15Volex (LON:VLX) Is Increasing Its Dividend To $0.026\nJun 25Volex (LON:VLX) Is Paying Out A Larger Dividend Than Last Year\nNov 13Is There Now An Opportunity In Volex plc (LON:VLX)?\nOct 07A Look At The Intrinsic Value Of Volex plc (LON:VLX)\nMay 10Is Now The Time To Put Volex (LON:VLX) On Your Watchlist?\nApr 21At UK\u00a32.45, Is It Time To Put Volex plc (LON:VLX) On Your Watch List?\nMar 07Are Volex plc (LON:VLX) Investors Paying Above The Intrinsic Value?\nJan 09Here's Why I Think Volex (LON:VLX) Might Deserve Your Attention Today\nNov 29Volex (LON:VLX) Will Pay A Larger Dividend Than Last Year At UK\u00a30.012\nNov 14If You Like EPS Growth Then Check Out Volex (LON:VLX) Before It's Too Late\nAug 28Volex (LON:VLX) Has Announced That It Will Be Increasing Its Dividend To UK\u00a30.022\nJul 14What Does Volex plc's (LON:VLX) Share Price Indicate?\nMay 13Here's Why We Think Volex (LON:VLX) Is Well Worth Watching\nApr 07How Many Volex plc (LON:VLX) Shares Did Insiders Buy, In The Last Year?\nMar 10Volex plc (LON:VLX) Shares Could Be 32% Above Their Intrinsic Value Estimate\nFeb 24Revenue & Expenses Breakdown\nHow Volex makes and spends money. Based on latest reported earnings, on an LTM basis.\nEarnings and Revenue History\n| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |\n|---|---|---|---|---|\n| 30 Mar 25 | 1,087 | 48 | 148 | 0 |\n| 30 Dec 24 | 1,060 | 46 | 139 | 0 |\n| 29 Sep 24 | 1,034 | 44 | 129 | 0 |\n| 29 Jun 24 | 973 | 41 | 123 | 0 |\n| 31 Mar 24 | 913 | 39 | 117 | 0 |\n| 31 Dec 23 | 838 | 37 | 111 | 0 |\n| 01 Oct 23 | 763 | 36 | 106 | 0 |\n| 01 Jul 23 | 743 | 36 | 99 | 0 |\n| 02 Apr 23 | 723 | 37 | 92 | 0 |\n| 02 Jan 23 | 701 | 33 | 85 | 0 |\n| 02 Oct 22 | 679 | 30 | 79 | 0 |\n| 02 Jul 22 | 647 | 30 | 75 | 0 |\n| 03 Apr 22 | 615 | 30 | 71 | 0 |\n| 03 Jan 22 | 574 | 36 | 71 | 0 |\n| 03 Oct 21 | 534 | 41 | 71 | 0 |\n| 03 Jul 21 | 488 | 40 | 69 | 0 |\n| 04 Apr 21 | 443 | 39 | 67 | 0 |\n| 04 Jan 21 | 421 | 31 | 68 | 0 |\n| 04 Oct 20 | 398 | 22 | 68 | 0 |\n| 04 Jul 20 | 395 | 19 | 68 | 0 |\n| 05 Apr 20 | 391 | 15 | 67 | 0 |\n| 05 Jan 20 | 388 | 14 | 64 | 0 |\n| 29 Sep 19 | 385 | 14 | 61 | 0 |\n| 29 Jun 19 | 379 | 11 | 57 | 0 |\n| 31 Mar 19 | 372 | 9 | 53 | 0 |\n| 31 Dec 18 | 358 | 6 | 51 | 0 |\n| 30 Sep 18 | 343 | 4 | 50 | 0 |\n| 30 Jun 18 | 333 | 4 | 48 | 0 |\n| 01 Apr 18 | 322 | 4 | 47 | 0 |\n| 01 Jan 18 | 319 | 4 | 47 | 0 |\n| 01 Oct 17 | 315 | 3 | 46 | 0 |\n| 01 Jul 17 | 317 | -2 | 47 | 0 |\n| 02 Apr 17 | 320 | -7 | 48 | 0 |\n| 02 Jan 17 | 332 | -9 | 51 | 0 |\n| 02 Oct 16 | 344 | -10 | 53 | 0 |\n| 02 Jul 16 | 356 | -6 | 53 | 0 |\n| 03 Apr 16 | 368 | -2 | 54 | 0 |\n| 03 Jan 16 | 380 | -3 | 60 | 0 |\n| 04 Oct 15 | 392 | -3 | 66 | 0 |\n| 04 Jul 15 | 408 | -7 | 70 | 0 |\n| 05 Apr 15 | 423 | -11 | 74 | 0 |\n| 05 Jan 15 | 424 | -14 | 73 | 0 |\n| 05 Oct 14 | 425 | -17 | 72 | 0 |\nQuality Earnings: VLX has high quality earnings.\nGrowing Profit Margin: VLX's current net profit margins (4.4%) are higher than last year (4.3%).\nFree Cash Flow vs Earnings Analysis\nPast Earnings Growth Analysis\nEarnings Trend: VLX's earnings have grown by 12.2% per year over the past 5 years.\nAccelerating Growth: VLX's earnings growth over the past year (21.9%) exceeds its 5-year average (12.2% per year).\nEarnings vs Industry: VLX earnings growth over the past year (21.9%) exceeded the Electrical industry 11.7%.\nReturn on Equity\nHigh ROE: VLX's Return on Equity (13.2%) is considered low.\nReturn on Assets\nReturn on Capital Employed\nDiscover strong past performing companies\nCompany Analysis and Financial Data Status\n| Data | Last Updated (UTC time) |\n|---|---|\n| Company Analysis | 2025/08/11 23:31 |\n| End of Day Share Price | 2025/08/11 00:00 |\n| Earnings | 2025/03/30 |\n| Annual Earnings | 2025/03/30 |\nData Sources\nThe data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.\n| Package | Data | Timeframe | Example US Source * |\n|---|---|---|---|\n| Company Financials | 10 years |\n| |\n| Analyst Consensus Estimates | +3 years |\n|\n|\n| Market Prices | 30 years |\n| |\n| Ownership | 10 years |\n| |\n| Management | 10 years |\n| |\n| Key Developments | 10 years |\n|\n* Example for US securities, for non-US equivalent regulatory forms and sources are used.\nUnless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.\nAnalysis Model and Snowflake\nDetails of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.\nLearn about the world class team who designed and built the Simply Wall St analysis model.\nIndustry and Sector Metrics\nOur industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.\nAnalyst Sources\nVolex plc is covered by 17 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.\n| Analyst | Institution |\n|---|---|\n| Eleanor Spencer | Berenberg |\n| Andrew Simms | Berenberg |\n| Matthew Abraham | Berenberg |"
    },
    {
      "url": "https://simplywall.st/discover/investing-ideas/434426/us-transformative-artificial-intelligence-ai-healthcare-stocks/global?blueprint=3982641&utm_medium=finance_user&utm_campaign=investing-ideas&utm_source=yahoo&utm_content=ai-healthcare",
      "text": "Results\n25\nArtificial intelligence (AI) is set to transform healthcare by enhancing diagnostics, personalizing medicine, boosting operational efficiency, expanding remote care, and accelerating research. AI outperforms humans in detecting diseases like cancer from scans, tailors treatments using genetic and lifestyle data, and streamlines hospital workflows with tools like predictive analytics and automated transcription. It powers telemedicine, monitors chronic conditions in real-time, and speeds up drug discovery by analyzing vast datasets for insights into complex diseases. Despite challenges like data privacy, bias, and integration costs, AI\u2019s ability to improve accuracy, access, and affordability could save billions and extend lives, marking a seismic shift in healthcare delivery and outcomes.\n25 companies\nCaris Life Sciences\nMarket Cap: US$8.4b\nAn artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally.\nCAI\nUS$30.21\n7D\n-0.3%\n1Y\nn/a\nRakovina Therapeutics\nMarket Cap: US$11.4m\nA biopharmaceutical research company, engages in the research and development of cancer treatments based on novel series of small-molecule DNA-damage response targets.\nRKVT.F\nUS$0.42\n7D\n19.3%\n1Y\nn/a\nCosmo Pharmaceuticals\nMarket Cap: US$889.4m\nFocuses on the development and commercialization products for gastroenterology, dermatology, and healthtech worldwide.\nCMOP.F\nUS$75.00\n7D\n0%\n1Y\n-8.5%\nGubra\nMarket Cap: US$5.8b\nA biotech company, focuses on the pre-clinical contract research and peptide-based drug discovery within metabolic and fibrotic diseases in Europe, North America, and internationally.\nGUBR.F\nUS$60.15\n7D\n0%\n1Y\nn/a\nEvaxion\nMarket Cap: US$17.9m\nA clinical-stage biotech company, develops artificial intelligence-powered immunology vaccines.\nEVAX\nUS$2.77\n7D\n1.8%\n1Y\n-77.8%\nImmunoPrecise Antibodies\nMarket Cap: US$92.3m\nOperates as an AI-driven biotherapeutic research, technology, and scientifically robust life science company.\nIPA\nUS$1.90\n7D\n3.8%\n1Y\n219.9%\nEvolent Health\nMarket Cap: US$1.0b\nThrough its subsidiary, provides specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States.\nEVH\nUS$9.22\n7D\n-5.6%\n1Y\n-63.5%\nGeneDx Holdings\nMarket Cap: US$3.2b\nA genomics company, provides genetic testing services.\nWGS\nUS$110.54\n7D\n3.6%\n1Y\n223.7%\nWELL Health Technologies\nMarket Cap: US$1.2b\nOperates as a practitioner-focused digital healthcare company in Canada, the United States, and internationally.\nWHTC.F\nUS$3.51\n7D\n7.7%\n1Y\n5.7%\nRevenio Group Oyj\nMarket Cap: US$646.5m\nProvides ophthalmological devices and software solutions for the diagnosis of glaucoma, macular degeneration, and diabetic retinopathy in Finland, the United States, and internationally.\nREVX.F\nUS$31.47\n7D\n0%\n1Y\nn/a\nRadNet\nMarket Cap: US$4.1b\nProvides outpatient diagnostic imaging services in the United States and internationally.\nRDNT\nUS$62.00\n7D\n11.2%\n1Y\n0.6%\nCareCloud\nMarket Cap: US$113.2m\nA healthcare information technology (IT) company, provides technology-enabled business solutions, Software-as-a-Service offerings, and related business services to healthcare providers and hospitals primarily in the United States.\nCCLD\nUS$2.56\n7D\n7.6%\n1Y\n25.5%\nBioXcel Therapeutics\nMarket Cap: US$24.5m\nTogether with its subsidiary, OnkosXcel Therapeutics LLC, operates as a biopharmaceutical company that utilizes artificial intelligence approaches to develop medicines in neuroscience and immuno-oncology in the United States.\nBTAI\nUS$6.40\n7D\n152.0%\n1Y\n-39.2%\nSimulations Plus\nMarket Cap: US$285.2m\nDevelops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide.\nSLP\nUS$13.87\n7D\n6.8%\n1Y\n-61.8%\nPerimeter Medical Imaging AI\nMarket Cap: US$32.9m\nA medical technology company, provides advanced imaging solutions to address unmet medical needs.\nPYNK.F\nUS$0.19\n7D\n-1.3%\n1Y\n-41.4%\nNano-X Imaging\nMarket Cap: US$296.8m\nDevelops a commercial-grade tomographic imaging device with a digital X-ray source.\nNNOX\nUS$4.71\n7D\n-0.8%\n1Y\n-30.0%\nCeriBell\nMarket Cap: US$473.3m\nOperates as a medical technology company focuses on transforming the diagnosis and management of patients with serious neurological conditions in the United States.\nCBLL\nUS$12.12\n7D\n-20.4%\n1Y\nn/a\nGuardant Health\nMarket Cap: US$6.8b\nA precision oncology company, provides blood and tissue tests, and data sets in the United States and internationally.\nGH\nUS$54.80\n7D\n24.0%\n1Y\n79.8%\nOmniAb\nMarket Cap: US$241.7m\nA biotechnology company, licenses discovery research technology to pharmaceutical and biotech companies, and academic institutions to enable the discovery of therapeutics in the United States, Europe, Japan, China, and Canada.\nOABI\nUS$1.96\n7D\n0.5%\n1Y\n-52.5%\nXtalPi Holdings\nMarket Cap: US$28.6b\nAn investment holding company, engages in the provision of robotics and drug discovery solutions in Mainland China, the United States, and internationally.\nQNTP.F\nUS$0.77\n7D\n12.9%\n1Y\nn/a\nNeuroOne Medical Technologies\nMarket Cap: US$37.3m\nA medical technology company, provides solutions for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording in the United States.\nNMTC\nUS$0.74\n7D\n-10.3%\n1Y\n-1.6%\nHealwell AI\nMarket Cap: US$392.1m\nA healthcare artificial intelligence company, develops and commercializes clinical decision support systems in Canada, New Zealand, Australia, and the United Kingdom.\nHWAI.F\nUS$1.03\n7D\n14.4%\n1Y\n-31.3%\nAbsci\nMarket Cap: US$409.6m\nOperates as a data-first generative artificial intelligence (AI) drug creation company in the United States.\nABSI\nUS$2.85\n7D\n-4.7%\n1Y\n-22.1%\nVeradigm\nMarket Cap: US$806.7m\nA healthcare technology company, provides information technology solutions to healthcare providers, payers, and biopharma markets in the United States and internationally.\nMDRX\nUS$4.65\n7D\n-4.1%\n1Y\n-51.1%\nPersonalis\nMarket Cap: US$399.9m\nDevelops, markets, and sells advanced cancer genomic tests and services in the United States and internationally.\nPSNL\nUS$4.50\n7D\n-19.2%\n1Y\n4.4%"
    },
    {
      "url": "https://simplywall.st/company/id/EC2EBDE3-CDAF-4D15-BF4E-0EAF04B38F06/valuation?blueprint=3982641&utm_medium=finance_user&utm_campaign=conclusion&utm_source=yahoo",
      "text": "Is VLX undervalued compared to its fair value, analyst forecasts and its price relative to the market?\nValuation Score\n2/6\nValuation Score 2/6\nBelow Fair Value\nSignificantly Below Fair Value\nPrice-To-Earnings vs Peers\nPrice-To-Earnings vs Industry\nPrice-To-Earnings vs Fair Ratio\nAnalyst Forecast\nShare Price vs Fair Value\nWhat is the Fair Price of VLX when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.\nDiscounted Cash Flow\nSimply Wall St\nUK\u00a32.67\nFair Value\n34.5% overvalued intrinsic discount\n5\nNumber of Analysts\nBelow Fair Value: VLX (\u00a33.6) is trading above our estimate of fair value (\u00a32.67)\nSignificantly Below Fair Value: VLX is trading above our estimate of fair value.\nKey Valuation Metric\nWhich metric is best to use when looking at relative valuation for VLX?\nKey metric: As VLX is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.\nThe above table shows the Price to Earnings ratio for VLX. This is calculated by dividing VLX's market cap by their current\nearnings.\nWhat is VLX's PE Ratio?\nPE Ratio\n18.4x\nEarnings\nUS$47.90m\nMarket Cap\nUS$883.27m\nVLX key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.\nPrice-To-Earnings vs Industry: VLX is good value based on its Price-To-Earnings Ratio (18.4x) compared to the European Electrical industry average (19.2x).\nPrice to Earnings Ratio vs Fair Ratio\nWhat is VLX's PE Ratio\ncompared to its\nFair PE Ratio?\nThis is the expected PE Ratio taking into\naccount the company's forecast earnings growth, profit margins\nand other risk factors.\nVLX PE Ratio vs Fair Ratio.\nFair Ratio\nCurrent PE Ratio\n18.4x\nFair PE Ratio\n21x\nPrice-To-Earnings vs Fair Ratio: VLX is good value based on its Price-To-Earnings Ratio (18.4x) compared to the estimated Fair Price-To-Earnings Ratio (21x).\nAnalyst Price Targets\nWhat is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?\nThe above table shows the analyst VLX forecast and predictions for the stock price in 12 month\u2019s time.\nDate\nShare Price\nAverage 1Y Price Target\nDispersion\nHigh\nLow\n1Y Actual price\nAnalysts\nCurrent\nUK\u00a33.60\nUK\u00a33.95\n+9.85%\n10.34%\nUK\u00a34.30\nUK\u00a33.22\nn/a\n5\nAug \u201926\nUK\u00a33.68\nUK\u00a34.00\n+8.72%\n10.54%\nUK\u00a34.37\nUK\u00a33.22\nn/a\n5\nJul \u201926\nUK\u00a33.67\nUK\u00a33.64\n-0.73%\n9.78%\nUK\u00a34.11\nUK\u00a33.15\nn/a\n4\nJun \u201926\nUK\u00a32.89\nUK\u00a33.53\n+22.19%\n7.62%\nUK\u00a33.95\nUK\u00a33.24\nn/a\n6\nMay \u201926\nUK\u00a32.58\nUK\u00a33.61\n+39.83%\n7.20%\nUK\u00a33.97\nUK\u00a33.27\nn/a\n5\nApr \u201926\nUK\u00a32.42\nUK\u00a34.04\n+67.10%\n12.55%\nUK\u00a34.85\nUK\u00a33.40\nn/a\n5\nMar \u201926\nUK\u00a32.70\nUK\u00a34.22\n+56.46%\n13.68%\nUK\u00a34.99\nUK\u00a33.43\nn/a\n6\nFeb \u201926\nUK\u00a32.90\nUK\u00a34.29\n+47.89%\n14.06%\nUK\u00a35.10\nUK\u00a33.51\nn/a\n6\nJan \u201926\nUK\u00a32.82\nUK\u00a34.40\n+56.17%\n12.40%\nUK\u00a35.03\nUK\u00a33.65\nn/a\n5\nDec \u201925\nUK\u00a32.89\nUK\u00a34.35\n+50.47%\n8.99%\nUK\u00a35.00\nUK\u00a34.00\nn/a\n4\nNov \u201925\nUK\u00a33.32\nUK\u00a34.48\n+35.16%\n11.05%\nUK\u00a35.16\nUK\u00a34.01\nn/a\n5\nOct \u201925\nUK\u00a33.29\nUK\u00a34.20\n+27.66%\n7.72%\nUK\u00a34.75\nUK\u00a33.94\nn/a\n4\nSep \u201925\nUK\u00a33.64\nUK\u00a34.30\n+18.27%\n9.10%\nUK\u00a34.95\nUK\u00a33.98\nn/a\n4\nAug \u201925\nUK\u00a33.52\nUK\u00a34.30\n+22.47%\n9.10%\nUK\u00a34.95\nUK\u00a33.98\nUK\u00a33.68\n4\nJul \u201925\nUK\u00a33.35\nUK\u00a34.32\n+28.87%\n9.33%\nUK\u00a35.00\nUK\u00a34.00\nUK\u00a33.67\n4\nJun \u201925\nUK\u00a33.52\nUK\u00a34.40\n+25.22%\n11.49%\nUK\u00a35.24\nUK\u00a33.87\nUK\u00a32.89\n5\nMay \u201925\nUK\u00a33.13\nUK\u00a34.47\n+43.15%\n12.00%\nUK\u00a35.36\nUK\u00a33.95\nUK\u00a32.58\n5\nApr \u201925\nUK\u00a32.88\nUK\u00a34.47\n+55.06%\n11.30%\nUK\u00a35.28\nUK\u00a33.96\nUK\u00a32.42\n5\nMar \u201925\nUK\u00a32.82\nUK\u00a34.47\n+58.36%\n11.30%\nUK\u00a35.28\nUK\u00a33.96\nUK\u00a32.70\n5\nFeb \u201925\nUK\u00a33.14\nUK\u00a34.48\n+42.71%\n11.51%\nUK\u00a35.24\nUK\u00a33.95\nUK\u00a32.90\n5\nJan \u201925\nUK\u00a33.19\nUK\u00a34.63\n+45.08%\n11.11%\nUK\u00a35.27\nUK\u00a33.98\nUK\u00a32.82\n4\nDec \u201924\nUK\u00a33.10\nUK\u00a34.63\n+49.29%\n11.11%\nUK\u00a35.27\nUK\u00a33.98\nUK\u00a32.89\n4\nNov \u201924\nUK\u00a32.82\nUK\u00a34.44\n+57.44%\n15.99%\nUK\u00a35.32\nUK\u00a33.33\nUK\u00a33.32\n5\nOct \u201924\nUK\u00a33.15\nUK\u00a34.33\n+37.62%\n16.54%\nUK\u00a35.32\nUK\u00a33.18\nUK\u00a33.29\n6\nSep \u201924\nUK\u00a33.22\nUK\u00a34.33\n+34.41%\n16.54%\nUK\u00a35.32\nUK\u00a33.18\nUK\u00a33.64\n6\nAug \u201924\nUK\u00a32.92\nUK\u00a34.12\n+41.08%\n15.12%\nUK\u00a35.27\nUK\u00a33.16\nUK\u00a33.52\n6\nAnalystConsensusTarget\nConsensus Narrative from 5 Analysts\nUK\u00a33.95\nFair Value\n9.0% undervalued intrinsic discount\n5\nNumber of Analysts\nAnalyst Forecast: Target price is less than 20% higher than the current share price.\nDiscover undervalued companies\n7D\n1Y\n7D\n1Y\n7D\n1Y\nCompany Analysis and Financial Data Status\nData\nLast Updated (UTC time)\nCompany Analysis\n2025/08/11 05:38\nEnd of Day Share Price\n2025/08/11 00:00\nEarnings\n2025/03/30\nAnnual Earnings\n2025/03/30\nData Sources\nThe data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.\n* Example for US securities, for non-US equivalent regulatory forms and sources are used.\nUnless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.\nAnalysis Model and Snowflake\nDetails of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.\nLearn about the world class team who designed and built the Simply Wall St analysis model.\nIndustry and Sector Metrics\nOur industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.\nAnalyst Sources\nVolex plc is covered by 17 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day."
    },
    {
      "url": "https://simplywall.st/company/id/EC2EBDE3-CDAF-4D15-BF4E-0EAF04B38F06?blueprint=3982641&utm_medium=finance_user&utm_campaign=narratives-news-header&utm_source=yahoo&utm_content=narrative-header-company-report",
      "text": "Volex (VLX) Stock Overview\nManufactures and sells power and data cables in North America, Europe, and Asia. More details\n| Snowflake Score | |\n|---|---|\n| Valuation | 2/6 |\n| Future Growth | 1/6 |\n| Past Performance | 5/6 |\n| Financial Health | 5/6 |\n| Dividends | 2/6 |\nVLX Community Fair Values\nSee what 19 others think this stock is worth. Follow their fair value or set your own to get alerts.\nVolex plc Competitors\nPrice History & Performance\n| Historical stock prices | |\n|---|---|\n| Current Share Price | UK\u00a33.60 |\n| 52 Week High | UK\u00a33.94 |\n| 52 Week Low | UK\u00a31.90 |\n| Beta | 0.96 |\n| 1 Month Change | -2.18% |\n| 3 Month Change | 34.39% |\n| 1 Year Change | 4.81% |\n| 3 Year Change | 11.13% |\n| 5 Year Change | 119.21% |\n| Change since IPO | 38.27% |\nRecent News & Updates\nVolex (LON:VLX) Has Announced That It Will Be Increasing Its Dividend To $0.03\nJul 17Volex plc's (LON:VLX) 26% Price Boost Is Out Of Tune With Earnings\nJul 06Volex (LON:VLX) Is Increasing Its Dividend To $0.03\nJul 02Recent updates\nVolex (LON:VLX) Has Announced That It Will Be Increasing Its Dividend To $0.03\nJul 17Volex plc's (LON:VLX) 26% Price Boost Is Out Of Tune With Earnings\nJul 06Volex (LON:VLX) Is Increasing Its Dividend To $0.03\nJul 02Volex (LON:VLX) Hasn't Managed To Accelerate Its Returns\nJun 27Volex plc's (LON:VLX) 27% Dip In Price Shows Sentiment Is Matching Earnings\nApr 05EV Partnerships, Including Tesla, Will Drive Future Opportunities\nStrategic expansions and partnerships in emerging and high-growth sectors like EVs position Volex for robust future revenue growth.Here's What To Make Of Volex's (LON:VLX) Decelerating Rates Of Return\nJan 15Earnings Tell The Story For Volex plc (LON:VLX)\nDec 13Volex (LON:VLX) Will Pay A Dividend Of $0.015\nNov 18Volex plc's (LON:VLX) Intrinsic Value Is Potentially 24% Below Its Share Price\nNov 16We Think That There Are Some Issues For Volex (LON:VLX) Beyond Its Promising Earnings\nJul 05Volex's (LON:VLX) Upcoming Dividend Will Be Larger Than Last Year's\nJun 29Volex plc (LON:VLX) Stocks Shoot Up 25% But Its P/E Still Looks Reasonable\nMay 10Is Now The Time To Put Volex (LON:VLX) On Your Watchlist?\nApr 19We Think Volex (LON:VLX) Can Stay On Top Of Its Debt\nFeb 22At UK\u00a32.88, Is It Time To Put Volex plc (LON:VLX) On Your Watch List?\nOct 10Is Volex (LON:VLX) A Risky Investment?\nAug 15Volex (LON:VLX) Is Increasing Its Dividend To $0.026\nJun 25Volex (LON:VLX) Is Paying Out A Larger Dividend Than Last Year\nNov 13Is There Now An Opportunity In Volex plc (LON:VLX)?\nOct 07A Look At The Intrinsic Value Of Volex plc (LON:VLX)\nMay 10Is Now The Time To Put Volex (LON:VLX) On Your Watchlist?\nApr 21At UK\u00a32.45, Is It Time To Put Volex plc (LON:VLX) On Your Watch List?\nMar 07Are Volex plc (LON:VLX) Investors Paying Above The Intrinsic Value?\nJan 09Here's Why I Think Volex (LON:VLX) Might Deserve Your Attention Today\nNov 29Volex (LON:VLX) Will Pay A Larger Dividend Than Last Year At UK\u00a30.012\nNov 14If You Like EPS Growth Then Check Out Volex (LON:VLX) Before It's Too Late\nAug 28Volex (LON:VLX) Has Announced That It Will Be Increasing Its Dividend To UK\u00a30.022\nJul 14What Does Volex plc's (LON:VLX) Share Price Indicate?\nMay 13Here's Why We Think Volex (LON:VLX) Is Well Worth Watching\nApr 07How Many Volex plc (LON:VLX) Shares Did Insiders Buy, In The Last Year?\nMar 10Volex plc (LON:VLX) Shares Could Be 32% Above Their Intrinsic Value Estimate\nFeb 24Shareholder Returns\n| VLX | GB Electrical | GB Market | |\n|---|---|---|---|\n| 7D | -0.8% | 0.8% | 3.2% |\n| 1Y | 4.8% | -7.7% | 16.4% |\nReturn vs Industry: VLX exceeded the UK Electrical industry which returned -7.7% over the past year.\nReturn vs Market: VLX underperformed the UK Market which returned 16.4% over the past year.\nPrice Volatility\n| VLX volatility | |\n|---|---|\n| VLX Average Weekly Movement | 6.3% |\n| Electrical Industry Average Movement | 8.0% |\n| Market Average Movement | 5.0% |\n| 10% most volatile stocks in GB Market | 11.2% |\n| 10% least volatile stocks in GB Market | 2.6% |\nStable Share Price: VLX has not had significant price volatility in the past 3 months compared to the UK market.\nVolatility Over Time: VLX's weekly volatility (6%) has been stable over the past year.\nAbout the Company\n| Founded | Employees | CEO | Website |\n|---|---|---|---|\n| 1892 | 14,000 | n/a | www.volex.com |\nVolex plc manufactures and sells power and data cables in North America, Europe, and Asia. It provides integrated manufacturing services, such as PCB assembly, box build, and complex cable assemblies; electric vehicle charging solutions; consumer cable harness and power products; copper interconnect cables and data transfer cables; and data center power cables and power cords. The company also offers plugs, connectors, and receptacles, as well as custom ruggedized wiring harnesses and battery cables.\nVolex plc Fundamentals Summary\n| VLX fundamental statistics | |\n|---|---|\n| Market cap | UK\u00a3657.79m |\n| Earnings (TTM) | UK\u00a335.67m |\n| Revenue (TTM) | UK\u00a3809.15m |\nIs VLX overvalued?\nSee Fair Value and valuation analysisEarnings & Revenue\n| VLX income statement (TTM) | |\n|---|---|\n| Revenue | US$1.09b |\n| Cost of Revenue | US$853.70m |\n| Gross Profit | US$232.80m |\n| Other Expenses | US$184.90m |\n| Earnings | US$47.90m |\nLast Reported Earnings\nMar 30, 2025\nNext Earnings Date\nn/a\n| Earnings per share (EPS) | 0.26 |\n| Gross Margin | 21.43% |\n| Net Profit Margin | 4.41% |\n| Debt/Equity Ratio | 44.2% |\nHow did VLX perform over the long term?\nSee historical performance and comparisonDividends\nDoes VLX pay a reliable dividends?\nSee VLX dividend history and benchmarks| Volex dividend dates | |\n|---|---|\n| Ex Dividend Date | Jul 31 2025 |\n| Dividend Pay Date | Sep 05 2025 |\n| Days until Ex dividend | 12 days |\n| Days until Dividend pay date | 24 days |\nDoes VLX pay a reliable dividends?\nSee VLX dividend history and benchmarksCompany Analysis and Financial Data Status\n| Data | Last Updated (UTC time) |\n|---|---|\n| Company Analysis | 2025/08/11 23:31 |\n| End of Day Share Price | 2025/08/11 00:00 |\n| Earnings | 2025/03/30 |\n| Annual Earnings | 2025/03/30 |\nData Sources\nThe data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.\n| Package | Data | Timeframe | Example US Source * |\n|---|---|---|---|\n| Company Financials | 10 years |\n| |\n| Analyst Consensus Estimates | +3 years |\n|\n|\n| Market Prices | 30 years |\n| |\n| Ownership | 10 years |\n| |\n| Management | 10 years |\n| |\n| Key Developments | 10 years |\n|\n* Example for US securities, for non-US equivalent regulatory forms and sources are used.\nUnless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.\nAnalysis Model and Snowflake\nDetails of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.\nLearn about the world class team who designed and built the Simply Wall St analysis model.\nIndustry and Sector Metrics\nOur industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.\nAnalyst Sources\nVolex plc is covered by 17 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.\n| Analyst | Institution |\n|---|---|\n| Eleanor Spencer | Berenberg |\n| Andrew Simms | Berenberg |\n| Matthew Abraham | Berenberg |"
    },
    {
      "url": "https://simplywall.st/company/id/EC2EBDE3-CDAF-4D15-BF4E-0EAF04B38F06?blueprint=3982641&utm_medium=finance_user&utm_campaign=cta&utm_source=yahoo",
      "text": "Volex (VLX) Stock Overview\nManufactures and sells power and data cables in North America, Europe, and Asia. More details\n| Snowflake Score | |\n|---|---|\n| Valuation | 2/6 |\n| Future Growth | 1/6 |\n| Past Performance | 5/6 |\n| Financial Health | 5/6 |\n| Dividends | 2/6 |\nVLX Community Fair Values\nSee what 19 others think this stock is worth. Follow their fair value or set your own to get alerts.\nVolex plc Competitors\nPrice History & Performance\n| Historical stock prices | |\n|---|---|\n| Current Share Price | UK\u00a33.60 |\n| 52 Week High | UK\u00a33.94 |\n| 52 Week Low | UK\u00a31.90 |\n| Beta | 0.96 |\n| 1 Month Change | -2.18% |\n| 3 Month Change | 34.39% |\n| 1 Year Change | 4.81% |\n| 3 Year Change | 11.13% |\n| 5 Year Change | 119.21% |\n| Change since IPO | 38.27% |\nRecent News & Updates\nVolex (LON:VLX) Has Announced That It Will Be Increasing Its Dividend To $0.03\nJul 17Volex plc's (LON:VLX) 26% Price Boost Is Out Of Tune With Earnings\nJul 06Volex (LON:VLX) Is Increasing Its Dividend To $0.03\nJul 02Recent updates\nVolex (LON:VLX) Has Announced That It Will Be Increasing Its Dividend To $0.03\nJul 17Volex plc's (LON:VLX) 26% Price Boost Is Out Of Tune With Earnings\nJul 06Volex (LON:VLX) Is Increasing Its Dividend To $0.03\nJul 02Volex (LON:VLX) Hasn't Managed To Accelerate Its Returns\nJun 27Volex plc's (LON:VLX) 27% Dip In Price Shows Sentiment Is Matching Earnings\nApr 05EV Partnerships, Including Tesla, Will Drive Future Opportunities\nStrategic expansions and partnerships in emerging and high-growth sectors like EVs position Volex for robust future revenue growth.Here's What To Make Of Volex's (LON:VLX) Decelerating Rates Of Return\nJan 15Earnings Tell The Story For Volex plc (LON:VLX)\nDec 13Volex (LON:VLX) Will Pay A Dividend Of $0.015\nNov 18Volex plc's (LON:VLX) Intrinsic Value Is Potentially 24% Below Its Share Price\nNov 16We Think That There Are Some Issues For Volex (LON:VLX) Beyond Its Promising Earnings\nJul 05Volex's (LON:VLX) Upcoming Dividend Will Be Larger Than Last Year's\nJun 29Volex plc (LON:VLX) Stocks Shoot Up 25% But Its P/E Still Looks Reasonable\nMay 10Is Now The Time To Put Volex (LON:VLX) On Your Watchlist?\nApr 19We Think Volex (LON:VLX) Can Stay On Top Of Its Debt\nFeb 22At UK\u00a32.88, Is It Time To Put Volex plc (LON:VLX) On Your Watch List?\nOct 10Is Volex (LON:VLX) A Risky Investment?\nAug 15Volex (LON:VLX) Is Increasing Its Dividend To $0.026\nJun 25Volex (LON:VLX) Is Paying Out A Larger Dividend Than Last Year\nNov 13Is There Now An Opportunity In Volex plc (LON:VLX)?\nOct 07A Look At The Intrinsic Value Of Volex plc (LON:VLX)\nMay 10Is Now The Time To Put Volex (LON:VLX) On Your Watchlist?\nApr 21At UK\u00a32.45, Is It Time To Put Volex plc (LON:VLX) On Your Watch List?\nMar 07Are Volex plc (LON:VLX) Investors Paying Above The Intrinsic Value?\nJan 09Here's Why I Think Volex (LON:VLX) Might Deserve Your Attention Today\nNov 29Volex (LON:VLX) Will Pay A Larger Dividend Than Last Year At UK\u00a30.012\nNov 14If You Like EPS Growth Then Check Out Volex (LON:VLX) Before It's Too Late\nAug 28Volex (LON:VLX) Has Announced That It Will Be Increasing Its Dividend To UK\u00a30.022\nJul 14What Does Volex plc's (LON:VLX) Share Price Indicate?\nMay 13Here's Why We Think Volex (LON:VLX) Is Well Worth Watching\nApr 07How Many Volex plc (LON:VLX) Shares Did Insiders Buy, In The Last Year?\nMar 10Volex plc (LON:VLX) Shares Could Be 32% Above Their Intrinsic Value Estimate\nFeb 24Shareholder Returns\n| VLX | GB Electrical | GB Market | |\n|---|---|---|---|\n| 7D | -0.8% | 0.8% | 3.2% |\n| 1Y | 4.8% | -7.7% | 16.4% |\nReturn vs Industry: VLX exceeded the UK Electrical industry which returned -7.7% over the past year.\nReturn vs Market: VLX underperformed the UK Market which returned 16.4% over the past year.\nPrice Volatility\n| VLX volatility | |\n|---|---|\n| VLX Average Weekly Movement | 6.3% |\n| Electrical Industry Average Movement | 8.0% |\n| Market Average Movement | 5.0% |\n| 10% most volatile stocks in GB Market | 11.2% |\n| 10% least volatile stocks in GB Market | 2.6% |\nStable Share Price: VLX has not had significant price volatility in the past 3 months compared to the UK market.\nVolatility Over Time: VLX's weekly volatility (6%) has been stable over the past year.\nAbout the Company\n| Founded | Employees | CEO | Website |\n|---|---|---|---|\n| 1892 | 14,000 | n/a | www.volex.com |\nVolex plc manufactures and sells power and data cables in North America, Europe, and Asia. It provides integrated manufacturing services, such as PCB assembly, box build, and complex cable assemblies; electric vehicle charging solutions; consumer cable harness and power products; copper interconnect cables and data transfer cables; and data center power cables and power cords. The company also offers plugs, connectors, and receptacles, as well as custom ruggedized wiring harnesses and battery cables.\nVolex plc Fundamentals Summary\n| VLX fundamental statistics | |\n|---|---|\n| Market cap | UK\u00a3657.79m |\n| Earnings (TTM) | UK\u00a335.67m |\n| Revenue (TTM) | UK\u00a3809.15m |\nIs VLX overvalued?\nSee Fair Value and valuation analysisEarnings & Revenue\n| VLX income statement (TTM) | |\n|---|---|\n| Revenue | US$1.09b |\n| Cost of Revenue | US$853.70m |\n| Gross Profit | US$232.80m |\n| Other Expenses | US$184.90m |\n| Earnings | US$47.90m |\nLast Reported Earnings\nMar 30, 2025\nNext Earnings Date\nn/a\n| Earnings per share (EPS) | 0.26 |\n| Gross Margin | 21.43% |\n| Net Profit Margin | 4.41% |\n| Debt/Equity Ratio | 44.2% |\nHow did VLX perform over the long term?\nSee historical performance and comparisonDividends\nDoes VLX pay a reliable dividends?\nSee VLX dividend history and benchmarks| Volex dividend dates | |\n|---|---|\n| Ex Dividend Date | Jul 31 2025 |\n| Dividend Pay Date | Sep 05 2025 |\n| Days until Ex dividend | 12 days |\n| Days until Dividend pay date | 24 days |\nDoes VLX pay a reliable dividends?\nSee VLX dividend history and benchmarksCompany Analysis and Financial Data Status\n| Data | Last Updated (UTC time) |\n|---|---|\n| Company Analysis | 2025/08/11 23:31 |\n| End of Day Share Price | 2025/08/11 00:00 |\n| Earnings | 2025/03/30 |\n| Annual Earnings | 2025/03/30 |\nData Sources\nThe data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.\n| Package | Data | Timeframe | Example US Source * |\n|---|---|---|---|\n| Company Financials | 10 years |\n| |\n| Analyst Consensus Estimates | +3 years |\n|\n|\n| Market Prices | 30 years |\n| |\n| Ownership | 10 years |\n| |\n| Management | 10 years |\n| |\n| Key Developments | 10 years |\n|\n* Example for US securities, for non-US equivalent regulatory forms and sources are used.\nUnless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.\nAnalysis Model and Snowflake\nDetails of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.\nLearn about the world class team who designed and built the Simply Wall St analysis model.\nIndustry and Sector Metrics\nOur industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.\nAnalyst Sources\nVolex plc is covered by 17 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.\n| Analyst | Institution |\n|---|---|\n| Eleanor Spencer | Berenberg |\n| Andrew Simms | Berenberg |\n| Matthew Abraham | Berenberg |"
    }
  ],
  "argos_summary": "Volex (LON:VLX) has seen a 34% increase in its stock price over the past three months, with a return on equity (ROE) of 13%, which aligns with the industry average. The company has achieved a consistent earnings growth rate of 12.2% annually, matching the Electrical industry average, while also increasing its dividend to $0.03. Despite its positive performance, analysts suggest that Volex's stock may be overvalued compared to its intrinsic value.",
  "argos_id": "SXQPAO7L9"
}